Prompteneering. Open the library →

Drug-Target Interaction Predictor for Kinase Inhibitor Selectivity Profiling Using DeepPurpose for Regulatory Submission Prep Document Revision Cycle

Predict and rank kinase selectivity profiles for 15 novel Type II kinase inhibitor compounds using DeepPurpose transformer models and cross-reference with KinomeScan experimental data.

• Best with Cursor
• Biotechnology & Life Sciences
• Computational Drug Discovery

Open this agent in the library →

More Computational Drug Discovery agents

• Computational Drug Discovery Hit-to-Lead StrategistComputational Drug Discovery · Claude
• Computational Drug Discovery Hit-to-Lead Strategist for Cross-Border Alignment Capa Planning WindowComputational Drug Discovery · ChatGPT
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA PlanningComputational Drug Discovery · Notion
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality ReviewComputational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Cross-Functional Rollout Scenario 0692Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Cross-Functional Rollout Scenario 1772Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Escalation Triage Scenario 0332Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Escalation Triage Scenario 1412Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Governance Audit Prep Scenario 0872Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Portfolio Prioritization Scenario 0512Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Portfolio Prioritization Scenario 1592Computational Drug Discovery · Copilot
• Computational Drug Discovery Hit-to-Lead Strategist for Exception Handling CAPA Planning for Governance Uplift Quarterly Quality Review for Regional Launch Scenario 1052Computational Drug Discovery · Copilot

All Computational Drug Discovery agents · All Biotechnology & Life Sciences agents